Streetbeat News

Stock Prices

NFLX

Netflix's (NFLX) short interest has decreased by 3.86% since the last report, with 9.65 million shares sold short, representing 2.24% of available shares. The short interest is below the peer group average of 7.45%. While a decline in short interest can indicate a more bullish sentiment, it does not necessarily predict a near-term price rise.

Portfolio Pulse from Benzinga Insights

January 03, 2024 | 1:15 pm

UNF

UniFirst (NYSE:UNF) reported Q1 earnings with an EPS of $2.38, beating estimates by 9.17% and showing a revenue increase of $51.73 million year-over-year. Despite beating last quarter's EPS estimate, the share price dropped by 2.7% the following day.

Portfolio Pulse from Benzinga Insights

January 03, 2024 | 1:15 pm

HNST

MAMA

TPB

UVV

Four consumer staples stocks with high RSI values, indicating potential overbought conditions, are The Honest Company, Inc. (HNST), Turning Point Brands, Inc. (TPB), Universal Corporation (UVV), and Mama's Creations, Inc. (MAMA). HNST expanded its partnership with Tinuiti, TPB reported a decrease in sales, UVV showed an increase in adjusted EPS, and MAMA priced a public offering. All stocks experienced price movements on Tuesday, with HNST and TPB closing lower, while UVV and MAMA closed nearly flat.

Portfolio Pulse from Avi Kapoor

January 03, 2024 | 1:13 pm

DPZ

Barclays analyst Jeffrey Bernstein has maintained an Underweight rating on Domino's Pizza (NYSE:DPZ) but increased the price target from $340 to $346.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 1:10 pm

ICCM

A new study has found that IceCure Medical's ProSense system, which is used in cryoablation procedures to destroy tumors, may also enhance the immune response against cancer by boosting CD8+ T cell response. This supports previous studies and suggests that ProSense could offer additional anti-cancer benefits beyond just tumor destruction.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 1:09 pm

PTVE

Citigroup analyst Anthony Pettinari has upgraded Pactiv Evergreen (PTVE) from Neutral to Buy and increased the price target from $10 to $16.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 1:07 pm

DYN

Dyne Therapeutics Inc (NASDAQ:DYN) reported positive initial clinical data from its ACHIEVE trial for DM1 and DELIVER trial for DMD, showing dose-dependent efficacy and a favorable safety profile. The data suggest that DYNE-101 and DYNE-251 could be more effective than the current standard of care, eteplirsen. The company plans to provide the next update in 2H of 2024. DYN shares surged 41.50% in premarket trading.

Portfolio Pulse from Vandana Singh

January 03, 2024 | 1:07 pm

HCAT

Evercore ISI Group analyst Elizabeth Anderson upgraded Health Catalyst (HCAT) from In-Line to Outperform and increased the price target from $9 to $11.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 1:06 pm

UNF

UniFirst (NYSE:UNF) reported Q1 earnings of $2.26 per share, surpassing the consensus estimate of $2.18 and showing an increase from $2.21 per share YoY. Sales reached $593.52M, exceeding estimates of $589.64M and marking a 9.55% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 1:06 pm

CANG

DAO

DOGZ

JFBR

NRDY

NVFY

RENT

STG

YOSH

YTRA

ZAPP

In Wednesday's pre-market session, several consumer discretionary stocks showed notable movements. Gainers included Nerdy (NRDY), Cango (CANG), Zapp Electric Vehicles (ZAPP), Rent the Runway (RENT), Yatra Online (YTRA), and Youdao (DAO), with increases ranging from 6.97% to 8.2%. Conversely, Nova Lifestyle (NVFY), Dogness (Intl) (DOGZ), Yoshiharu Global (YOSH), Sunlands Technology (STG), and Jeffs Brands (JFBR) experienced declines between 6.35% and 11.9%.

Portfolio Pulse from Benzinga Insights

January 03, 2024 | 1:06 pm